Transcat (TRNS) & Its Rivals Head-To-Head Review
Transcat (NASDAQ: TRNS) is one of 24 public companies in the “Electronic Component” industry, but how does it compare to its competitors? We will compare Transcat to similar businesses based on the strength of its institutional ownership, profitability, valuation, risk, earnings, dividends and analyst recommendations.
Insider and Institutional Ownership
52.9% of Transcat shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Electronic Component” companies are owned by institutional investors. 8.8% of Transcat shares are owned by insiders. Comparatively, 9.0% of shares of all “Electronic Component” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
This table compares Transcat and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Transcat has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Transcat’s competitors have a beta of 1.03, meaning that their average stock price is 3% more volatile than the S&P 500.
This is a breakdown of recent ratings and recommmendations for Transcat and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Transcat currently has a consensus price target of $20.00, suggesting a potential upside of 27.39%. As a group, “Electronic Component” companies have a potential upside of 0.24%. Given Transcat’s stronger consensus rating and higher probable upside, equities analysts plainly believe Transcat is more favorable than its competitors.
Earnings & Valuation
This table compares Transcat and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Transcat||$143.90 million||$4.52 million||23.09|
|Transcat Competitors||$1.24 billion||$140.56 million||91.77|
Transcat’s competitors have higher revenue and earnings than Transcat. Transcat is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Transcat competitors beat Transcat on 7 of the 13 factors compared.
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.